Showing results (251-260 of 674) with videos related to
Sort By:
Pageof 68
Trends in Pharmacological Sciences|October 8, 2008
Conformational changes involved in G-protein-coupled-receptor activationJürgen Wess, Sung-Jun Han, Soo-Kyung Kim, et al.Purinergic Signalling|July 5, 2008
Development of selective agonists and antagonists of P2Y receptorsKenneth A Jacobson, Andrei A Ivanov, Sonia de Castro, et al.Biochemical Pharmacology|April 1, 2020
Assessment of biased agonism at the A3 adenosine receptor using β-arrestin and miniGαi recruitment assaysEline Pottie, Dilip K Tosh, Zhan-Guo Gao, et al.Drug Development Research|May 3, 2016
Inhibition of Ecto-Apyrase and Ecto-ATPase by Pyridoxal Phosphate-Related CompoundsCarsten Hoffmann, Petra Heine, Gabi Pradel, et al.Molecules (Basel, Switzerland)|March 26, 2022
Dihydropyridines Potentiate ATP-Induced Currents Mediated by the Full-Length Human P2X5 ReceptorIda C Schiller, Kenneth A Jacobson, Zhiwei Wen, et al.European Journal of Pharmacology|August 4, 2023
Anti-inflammatory potency of novel ecto-5'-nucleotidase/CD73 inhibitors in astrocyte culture model of neuroinflammationKatarina Mihajlovic, Marija Adzic Bukvic, Milorad Dragic, et al.British Journal of Pharmacology|April 18, 2002
2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonistJosé L Boyer, Mary Adams, R Gnana Ravi, et al.Bioorganic & Medicinal Chemistry|September 24, 2008
Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1)Eun Joo Roh, Jason M Keller, Zoltan Olah, et al.Drug Development Research|July 10, 2012
Riboflavin: Inhibitory Effects on Receptors, G-Proteins, and Adenylate CyclaseJohn W Daly, Dan Shi, William L Padgett, et al.Pharmacological Reviews|February 10, 2011
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an updateBertil B Fredholm, Adriaan P IJzerman, Kenneth A Jacobson, et al.Pageof 68